Short- to intermediate-term follow-up in patients treated with the combination of 311-nm ultraviolet B phototherapy and biological agents

Br J Dermatol. 2014 Oct;171(4):915-7. doi: 10.1111/bjd.12992. Epub 2014 Aug 5.

Authors

M Inzinger¹, F J Legat, A Hofer, W Weger, A Gruber-Wackernagel, W Salmhofer, P Wolf

Affiliation

¹ Research Unit for Photodermatology, Department of Dermatology, Medical University of Graz, Graz, Austria.

PMID: 24665924
DOI: 10.1111/bjd.12992

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Biological Factors / therapeutic use*
Clinical Trials as Topic
Combined Modality Therapy
Female
Follow-Up Studies
Humans
Male
Melanoma / etiology
Middle Aged
Neoplasms, Radiation-Induced / etiology
Psoriasis / therapy*
Skin Neoplasms / etiology
Ultraviolet Therapy / methods*

Substances

Biological Factors